ARIEL TYRING, M.D.
Ophthalmology Physician · SEATTLE, WA
Individual Active NPI 1952720799
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 622 | 26,145 | $3,739,213 | $2,046,913 | $1,604,833 |
| 2023 | 559 | 20,956 | $3,663,276 | $1,942,462 | $1,522,870 |
| 2022 | 498 | 8,314 | $3,068,735 | $1,571,899 | $1,234,173 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 19,320 | $34 | $27 |
| 92134 | Imaging of retina | 1,605 | $47 | $36 |
| 92012 | Established patient problem focused exam of visual system | 1,105 | $105 | $82 |
| 67028 | Injection of drug into eye | 828 | $135 | $109 |
| J0178 | Injection, aflibercept, 1 mg | 822 | $827 | $650 |
| J0177 | Injection, aflibercept hd, 1 mg | 424 | $332 | $265 |
| 92014 | Established patient complete exam of visual system | 420 | $146 | $102 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 402 | $17 | $13 |
| 92250 | Photography of the retina | 265 | $43 | $33 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 210 | $28 | $20 |
| 92004 | New patient complete exam of visual system | 173 | $173 | $125 |
| J2778 | Injection, ranibizumab, 0.1 mg | 134 | $161 | $121 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | MD.MD.60840834 | WA |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Washington
- NPI 1114128519
- NPI 1740346378
- NPI 1114946555
- NPI 1942662168
- NPI 1053903344
- NPI 1750888749
- NPI 1073142949
- NPI 1073142220
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.